Related Experiment Video

Updated: Mar 28, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.9K

Endothelial Dysfunction by Flow-Mediated Vasodilatation in Chronic Kidney Disease

Vaibhav Shukla, Rahul Dey, Ashok Chandra

    The Journal of the Association of Physicians of India
    |December 30, 2015
    PubMed

    Insights

    Chronic kidney disease (CKD) patients exhibit significant endothelial dysfunction, particularly in later disease stages. This dysfunction, assessed via flow-mediated brachial artery vasodilatation, is more pronounced compared to healthy individuals.

    Area of Science:

    • Nephrology
    • Cardiovascular Medicine
    • Vascular Biology

    Background:

    • Chronic kidney disease (CKD) prevalence is rising globally.
    • Cardiovascular disease is the leading cause of mortality in CKD patients.
    • Endothelial dysfunction is a key factor in cardiovascular complications.

    Purpose of the Study:

    • To investigate endothelial dysfunction in CKD patients.
    • To compare endothelial function between CKD patients and healthy controls.
    • To assess the relationship between CKD stage and endothelial dysfunction.

    Main Methods:

    • Study included 35 CKD patients and 32 age/sex-matched controls.
    • Flow-mediated vasodilatation (FMD) of the brachial artery was assessed.
    • Anthropometric, hematological, and biochemical parameters were measured.

    Main Results:

    • CKD patients demonstrated significant endothelial dysfunction compared to controls, as measured by FMD.
    • Endothelial dysfunction was more severe in advanced stages of CKD.
    • Biochemical and anthropometric data supported the findings of impaired vascular function.

    Conclusions:

    • CKD is associated with significant endothelial dysfunction.
    • The severity of endothelial dysfunction increases with CKD progression.
    • Targeting endothelial dysfunction may be crucial for managing cardiovascular risk in CKD.
    Abstract

    More Related Videos

    Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test06:35

    Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

    Published on: April 27, 2016

    19.0K
    Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research08:42

    Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

    Published on: October 22, 2014

    28.1K

    Related Concept Videos

    Chronic Kidney Disease I: Introduction01:25

    Chronic Kidney Disease I: Introduction

    Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
    1.1K
    Chronic Kidney Disease II: Clinical Manifestations01:24

    Chronic Kidney Disease II: Clinical Manifestations

    Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
    936
    Chronic Kidney Disease III: Interprofessional Care01:28

    Chronic Kidney Disease III: Interprofessional Care

    Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
    609
    Chronic Kidney Disease IV: Nursing Management01:18

    Chronic Kidney Disease IV: Nursing Management

    Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
    596
    Acute Kidney Injury II: Pathophysiology01:29

    Acute Kidney Injury II: Pathophysiology

    Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
    1.9K
    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
    334